H 141 (Lithium 600 mg)
Pill imprint H 141 has been identified as Lithium carbonate 600 mg.
Lithium is used in the treatment of bipolar disorder; borderline personality disorder; intermittent explosive disorder; depression; mania (and more), and belongs to the drug class miscellaneous antipsychotic agents. There is positive evidence of human fetal risk during pregnancy. Lithium 600 mg is not a controlled substance under the Controlled Substance Act (CSA).
- Imprint:
- H 141
- Strength:
- 600 mg
- Color:
- Pink & White
- Shape:
- Capsule-shape
- Availability:
- Prescription only
- Drug Class:
- Miscellaneous antipsychotic agents
- Pregnancy Category:
- D - Positive evidence of risk
- CSA Schedule:
- Not a controlled drug
- Manufacturer:
- Camber Pharmaceuticals, Inc.
- National Drug Code (NDC):
- 65977-5046
- Inactive Ingredients:
- magnesium silicate
gelatin
titanium dioxide
sodium lauryl sulfate
FD&C Red No. 40
shellac
alcohol
isopropyl alcohol
butyl alcohol
propylene glycol
ammonia
ferrosoferric oxide
potassium hydroxide
More about lithium
Consumer resources
- Lithium
- Lithium controlled-release and extended-release tablets
- Lithium syrup
- Lithium (Advanced Reading)
- Other brands: Lithobid, Eskalith, Eskalith-CR
Professional resources
Related treatment guides
Disclaimer:
Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Copyright 2016 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.
